Metabolic Explorer Granted Patent for the production of Propylene Glycol
News Feb 27, 2006
Metabolic Explorer has announced that the FR2864967 Patent for the production of Propylene Glycol (MPG) by fermentation has been granted. The strain developed by Metabolic Explorer is designed to offer a competitive way to manufacture MPG from renewable resources.
METEX demonstrates its ability to develop proprietary strains with performant biochemical pathways using its integrated platform in strain evolution and optimisation.
This bioprocess that uses E. coli for the production of MPG and Acetone as co-product offers two advantages versus the current chemical process: The possibility to produce pure R or S MPG isomer when the chemical processes produces a racemic mixture. The bioprocess increases the value of MPG when it’s used as intermediates for performance products.
The use of renewable carbon sources when the chemical process uses propylene, a raw materiel with volatile and increasing price. The bioprocess offers a better and a sustainable economic for MPG production.
"The issuance of this new patent reinforces Metabolic Explorer’s pipeline of products positioning in industrial biotechnology," said Benjamin Gonzalez, CEO of Metabolic Explorer.
"Through this innovation we prove once again our capability to use our core competence to develop faster commodity chemicals using fermentation routes and to offer the chemical industry a unique value proposition for a better and sustainable growth."
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE
Molecule Prevents Common Cold Virus from Hijacking Human CellsNews
Researchers have lab-tested a molecule that can combat the common cold virus by preventing it from hijacking human cells.READ MORE
Improving Pharmaceuticals: Catalyst Specifically Tuned to Integrate Fluorine AtomsNews
In the race to create more potent and stable medicines, scientists know that adding fluorine can improve drug molecules. However, there is only one fluorination reaction known to occur in nature which is performed by complex and highly specialized enzymes that are difficult to replicate. Now, scientists have developed a new, streamlined molecule that can do the work of enzymes but be designed and controlled minutely.READ MORE
Comments | 0 ADD COMMENT
World Congress on Bio-organic and Medicinal Chemistry
Nov 12 - Nov 13, 2018